neuroleptic
CLW possesses a good therapeutic effect for neuroleptic salivation.
陈夏六君子丸对抗精神病药所致流涎疗效确切。
What is the risk of developing parkinsonism following neuroleptic use?
应用神经抑制药物后发生帕金森综合征的风险有多大?
Objective:To observe the therapeutic effect of Chenxia Liujunzi Wan (CLW) for neuroleptic salivation.
目的:观察陈夏六君子丸治疗抗精神病药流涎副作用的疗效。
What is the risk of developing parkinsonism following neuroleptic use? Noyes K. Holloway R.G.
应用神经抑制药物后发生帕金森综合征的风险有多大?
For example, parkinsonism is a frequent complication of use of metoclopramide and most neuroleptic agents.
如帕金森神经功能障碍（parkinsonism)往往是应用甲氧氯普胺（metoclopramide)的合并症，神经安定药大多已有此反应。
This is the largest neuroleptic withdrawal study of Alzheimer's patients and the only long-term one of its type.
这是规模最大的一次关于阿尔兹海默氏病患者神经抑制剂戒断的研究也是同类研究中为期时间最长的。
When we used this technique with different neuroleptic drugs, we were able to compare the relative effectiveness of the various compounds.
当我们把这一方法用于不同的神经松驰剂时，我们便能够比较各种化合物的相对效力。
The advance in abroad researches on the application of atypical neuroleptic in the treatment of child and juvenile bipdlar affective disorder is revievred.
综述了近年来国外应用非典型抗精神病药物治疗儿童及少年双相情感障碍的研究进展。
A rare but serious side effect that has been reported with this kind of medicine, including RISPERDAL(R), is known as neuroleptic malignant syndrome (NMS).
已报道的维思通等此类药的罕见但严重副作用为神经阻滞剂恶性综合征(NMS)。
Objective To explore the management couatermeasure,prognosis and the safety of reusing drugs in patients with neuroleptic malignant syndrome(NMS) caused by drugs.
目的探讨药源性恶性综合征处理对象、转归以及再次服用抗精神病药物的安全性。
Neuroleptic malignant syndrome (NMS) is a life-threatening, neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic drugs.
什么是'抗精神病药恶性综合征-药物引起的威胁生命的神经状态'?
Since the initial report of neuroleptic malignant syndrome (NMS) in 1960, lots of clinical data have been accumulated on the pathogenesis, manifestations and treatment of NMS.
自从1960年首次报道抗精神病药恶性综合征(NMS)后,大量的临床案例已使人们对于NMS的发病机制、临床表现和治疗有了较深的了解。
Methods:110 cases with neuroleptic salivation were allocated to two groups randomly,treatment group (56 cases) were given CLW for oral use and control group (54 cases) by artane or phenergan.
方法:将110例因使用抗精神病药致流涎的患者随机分为2组,治疗组56例,口服陈夏六君子丸; 对照组54例,使用安坦或非那根治疗。
These initial symptoms can oerlap considerably with those of other cardiac and non-cardiac conditions, including neuroleptic malignant syndrome (NMS), which may itself be caused by antipsychotics.
这些始发症状还与其他的心脏和非心脏的原因导致的疾病有很大相似之处，如抗精神病药物引起恶性综合征。
It was suggested that observation and care should be carried out in the periods of neuroleptic treatment to find the signs of sudden death in time, and further make effective measurements.
提出应用抗精神病药要加强巡视观察及监护，以便及时发现，采取积极有效的抢救措施。
Neuroleptic drugs radioreceptor assay test system
精神抑制药放射性受体测定系统
neuroleptic malignant-like syndrome
神经抑制剂恶性样综合征
NM neuroleptic malignant syndrome
抗精神病药恶性综合征
Neuroleptic malignant syndrome(NMS)
恶性综合征
The WHO analgesic ladder and neuroleptic malignant syndrome
WHO止痛三步用药法和抗精神病药的恶性综合症
neuroleptic malignant syndrome
抗精神病药的恶性综合征:一种罕见的有时是致死的反应, 特点为高烧、强直及昏迷
Keywords Neuroleptic;Procedure of response;Exponential curve;Correlation index;
抗精神病药;起效过程;指数曲线;相关指数;
Treatment of Neuroleptic Salivation by Chenxia Liujunzi Wan; A Clinical Observation of 56 Cases
陈夏六君子丸治疗抗精神病药流涎副作用56例疗效观察
The Management and Analysis of Resusing Drugs in 38 Patients with Neuroleptic Malignant Syndrome
38例药源性恶性综合征的处理对策及再用药分析
Keywords Neuroleptic malignant syndrome（NMS）;Clinical features;Misdiagnosis;Prognosis;
恶性综合征;临床特点;误诊;预后;
neurolept analgesia
神经安定镇痛术
neuroleptic agent
精神抑制剂, 安定剂
neuroleptic drug screen
精神抑制药物筛查
neuroleptic therapy
精神安定剂疗法
polyvalent neuroleptic
强安定药
long-acting neuroleptic
长效精神安定剂
hypnosedative neuroleptic
安眠镇静性安定药
neurolept
n. 精神抑制药, 安定药
neuroleptic
n. 精神抑制药, 安定药
neuroleptic drug
神经松弛药
neuroleptic medicine
神经松弛剂